A Study Evaluating IL28B Polymorphism in Patients With HBeAg-Negative Chronic Hepatitis B Treated With Pegasys (Peginterferon Alfa-2a) in Study ML18253
NCT01697501
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
88
Enrollment
INDUSTRY
Sponsor class
Conditions
Hepatitis B, Chronic
Interventions
OTHER:
Interleukin 28B testing
Sponsor
Hoffmann-La Roche